Company Filing History:
Years Active: 2020
Title: Koya Kimoto: Innovator in Cocrystal Technology
Introduction
Koya Kimoto is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cocrystal technologies. His innovative work has the potential to enhance the efficacy of various medicaments.
Latest Patents
Koya Kimoto holds a patent for a cocrystal, production method thereof, and medicament containing cocrystal. The patent describes a cocrystal of (S)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1H-1,2,4-triazol-5(4H)-one and an organic acid capable of forming a cocrystal with the compound. This invention is crucial for improving drug formulations and therapeutic outcomes.
Career Highlights
Koya Kimoto is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda has allowed him to focus on innovative solutions that address unmet medical needs. With 1 patent to his name, he continues to contribute to advancements in the pharmaceutical industry.
Collaborations
Koya has collaborated with esteemed colleagues, including Mitsuo Yamamoto and Masato Kitayama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Koya Kimoto's contributions to cocrystal technology exemplify the importance of innovation in the pharmaceutical field. His work not only enhances drug formulations but also paves the way for future advancements in medicine.